Barings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,572
Closed -$283K 214
2022
Q2
$283K Sell
7,572
-483
-6% -$18.1K 0.01% 254
2022
Q1
$357K Hold
8,055
0.01% 232
2021
Q4
$343K Sell
8,055
-1,083
-12% -$46.1K 0.01% 295
2021
Q3
$396K Buy
+9,138
New +$396K 0.01% 259
2021
Q2
Sell
-19,983
Closed -$772K 397
2021
Q1
$772K Sell
19,983
-20,303
-50% -$784K 0.02% 259
2020
Q4
$1.45M Sell
40,286
-721
-2% -$25.9K 0.04% 194
2020
Q3
$1.57M Sell
41,007
-5,222
-11% -$200K 0.04% 277
2020
Q2
$1.51M Hold
46,229
0.05% 227
2020
Q1
$1.51M Sell
46,229
-21,114
-31% -$689K 0.05% 227
2019
Q4
$3.05M Sell
67,343
-5,333
-7% -$241K 0.08% 193
2019
Q3
$2.96M Sell
72,676
-14,294
-16% -$582K 0.07% 206
2019
Q2
$3.74M Buy
86,970
+20,612
+31% +$886K 0.08% 192
2019
Q1
$2.55M Buy
66,358
+22,998
+53% +$883K 0.06% 236
2018
Q4
$1.53M Sell
43,360
-2,082
-5% -$73.6K 0.03% 297
2018
Q3
$1.75M Sell
45,442
-56,983
-56% -$2.19M 0.02% 373
2018
Q2
$3.35M Buy
102,425
+39,904
+64% +$1.3M 0.05% 240
2018
Q1
$1.71M Hold
62,521
0.02% 395
2017
Q4
$1.55M Buy
62,521
+47,200
+308% +$1.17M 0.02% 438
2017
Q3
$447K Hold
15,321
0.01% 672
2017
Q2
$425K Sell
15,321
-73,721
-83% -$2.04M 0.01% 659
2017
Q1
$2.21M Buy
89,042
+44,521
+100% +$1.11M 0.03% 556
2016
Q4
$963K Sell
44,521
-24,900
-36% -$539K 0.02% 463
2016
Q3
$1.65M Sell
69,421
-30,700
-31% -$731K 0.04% 317
2016
Q2
$2.34M Buy
+100,121
New +$2.34M 0.06% 260
2016
Q1
Sell
-43,025
Closed -$793K 937
2015
Q4
$793K Hold
43,025
0.02% 539
2015
Q3
$706K Sell
43,025
-2,100
-5% -$34.5K 0.02% 544
2015
Q2
$799K Sell
45,125
-2,400
-5% -$42.5K 0.02% 575
2015
Q1
$844K Sell
47,525
-90,400
-66% -$1.61M 0.02% 548
2014
Q4
$1.83M Sell
137,925
-9,100
-6% -$121K 0.04% 325
2014
Q3
$1.74M Sell
147,025
-48,400
-25% -$571K 0.04% 336
2014
Q2
$2.5M Buy
195,425
+133,800
+217% +$1.71M 0.07% 271
2014
Q1
$833K Sell
61,625
-63,700
-51% -$861K 0.03% 506
2013
Q4
$1.51M Buy
125,325
+4,000
+3% +$48.1K 0.06% 325
2013
Q3
$1.42M Buy
121,325
+58,300
+93% +$684K 0.06% 349
2013
Q2
$584K Buy
+63,025
New +$584K 0.03% 561